PUBLISHER: IMARC | PRODUCT CODE: 1347502
PUBLISHER: IMARC | PRODUCT CODE: 1347502
The global syringes market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
Syringes are medical devices used by healthcare professionals to withdraw fluid from the body or inject medication through intravenous (IV) or intramuscular ways into the bloodstream. They assist in managing the medical conditions of people, including psoriasis, allergies, arthritis, cancer, diabetes, hepatitis, infertility, migraines, multiple sclerosis, osteoporosis, blood clotting disorders, and human immunodeficiency virus (HIV). Several manufacturers are currently adopting advanced manufacturing processes and quality assurance procedures to produce syringes that provide research and development (R&D) personnel with superior accuracy and precision during auto sampling.
Governments of numerous countries are encouraging the fast and safe vaccination of people to reduce their probability of contracting coronavirus disease (COVID-19). This represents one of the key factors driving the need for effective syringes to meet vaccination targets. Apart from this, the growing prevalence of chronic diseases and the increasing healthcare-associated infection (HAI) cases are catalyzing the adoption of disposable syringes that are cost-effective, ready to use, and made of plastic. In addition to this, a significant rise in the percentage of people who are undergoing surgical interventions is augmenting the demand for single-use syringes for delivering anesthetics. Besides this, various initiatives, such as installing sharp containers in public places, undertaken by health agencies to address the increasing number of used syringes and promote safe injection practices are impelling the growth of the market. Furthermore, as farm animals are commonly exposed to diseases that can spread to humans, the increasing consumption of animal-derived products and the rising concerns about food safety are escalating the demand for combined vaccines and syringes. This can also be attributed to the growing adoption of companion animals and the emerging pet ownership and humanization trends.
IMARC Group provides an analysis of the key trends in each sub-segment of the global syringes market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, material, usage, distribution channel and end user.
General Syringes
Specialized Syringes
Insulin Syringes
Tuberculin Syringes
Allergy Syringes
Others
Glass Syringes
Polymer Syringes
Disposable Syringes
Conventional Syringes
Safety Syringes
Prefilled Syringes
Reusable Syringes
Offline
Online
Hospitals and Clinics
Diagnostic Centers
Speciality Centers
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Gerresheimer AG, Hindustan Syringes & Medical Devices Ltd., Nipro Corporation, Pfizer Inc., Retractable Technologies Inc., Schott AG, Smiths Group plc, Terumo Corporation and Thomas Scientific LLC.